Creating Biomedical Technologies to Improve Health

Search form

NEWS & EVENTS

Newsroom

Science Highlights • January 23, 2015
NIBIB-funded researchers have developed a novel 3D vaccine that could provide a more effective way to harness the immune system to fight cancer as well as infectious diseases. The vaccine spontaneously assembles into a scaffold once injected under the skin and is capable of recruiting, housing, and manipulating immune cells to generate a powerful immune response. The vaccine was recently found to be effective in delaying tumor growth in mice.
Grantee News • January 20, 2015

A research team including NIBIB-funded researchers has identified a stem cell in the bone marrow of mice that is capable of regenerating both bone and cartilage. The newly identified bone stem cell appears to be critical for skeletal development and could be used for novel treatment approaches for osteoarthritis, osteoporosis, and bone fractures. Find more information and a video at the Columbia University Medical Center Newsroom.

Grantee News • January 20, 2015

NIBIB grantee Mark Anastasio, PhD, Washington University in St. Louis, has been elected to the American Institute for Medical and Biological Engineering’s College of Fellows in recognition of his important contributions to biomedical engineering. The College of Fellows is made up of the top two percent of accomplished medical and biological engineers responsible for medical discovery and innovation in academia, industry and government. Read more about the award at engineering.wustl.edu.

Grantee News • January 15, 2015

This story by the University of Pennsylvania features NIBIB-funded researchers who are studying how cells interact over long distances within fibrous tissue, like that associated with many diseases of the liver, lungs and other organs. Read the full story at www.upenn.edu/pennnews.

Science Highlights • January 15, 2015

Nicole Carvajal receives award from the Society for Advancement of Hispanics/Chicanos and Native Americans in Science

Nicole Carvajal, a student researcher at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), has been named a 2014 Student Presenter Awardee by the Society for the Advancement of Hispanics/Chicanos and Native Americans in Science (SACNAS). Her work, entitled “Examination of diverse 3-D microenvironments using Atomic Force Microscopy” was presented at the annual SACNAS National Conference held in Los Angeles, California, October 16-18.

Grantee News • January 6, 2015

NIBIB-funded researchers at the University of California San Diego have developed a new non-invasive MRI technique that could help doctors better visualize tumors in the prostate. Unlike imaging techniques currently used, the new technique doesn't require an injection of a contrast agent. Read the full UCSD press release.

Grantee News • January 5, 2015

Scientific American named NIBIB-supported research at MIT one of 10 "World Changing Ideas" for 2014. The work involves a new method for controlling cells by squeezing them. Read the full article at http://www.scientificamerican.com

 

Grantee News • January 4, 2015

St. Louis Public Radio interviews NIBIB grantee Dr. Lihong Wang of Washginton University in St. Louis about his latest invention, an ultrafast camera that can reveal light pulses travelling in space by capturing events up to 100 billion frames per second. Combined with a microscope, the camera could be used to image chemical reaction inside of human cells.

NIBIB in the News • December 30, 2014

NIBIB Director Roderic I. Pettigrew, Ph.D., M.D. recently received the first-ever Gold Medal Award from the Academy of Radiology Research (ARR) for his extraordinary contributions in advancing radiology research. ARR is an alliance of 28 professional imaging societies, which works nationwide to enhance patient care through advances in biomedical imaging.

Press Releases • December 30, 2014
The National Institutes of Health has awarded grants totaling $7.9 million in 2014 to 25 research teams who are unraveling the workings of single cells, as part of an effort to spur development of personalized treatments that target disease at the cellular level. The grants are supported by the NIH Common Fund’s Single Cell Analysis Program (SCAP).

Pages